stella
beta
Effect of PCSK9 Inhibitors on Coronary Atherosclerotic Plaques Derived From Optical Coherence Tomography — Stella
Recruiting
Back to Coronary Artery Disease trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(1 site)
China
First Affiliated Hospital of Xinjiang Medical University, Ürümqi, Xinjiang
View full record on ClinicalTrials.gov